CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-02 | Molineaux Christopher P. Director | Grant or award · Restricted Stock Units | +4,507 | 4,507 | ||
| 2022-06-02 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2022-06-02 | MILANO VINCENT Director | Grant or award · Restricted Stock Units | +4,507 | 4,507 | ||
| 2022-06-02 | Mehra Anand Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2022-06-02 | Mehra Anand Director | Grant or award · Restricted Stock Units | +4,507 | 4,507 | ||
| 2022-06-02 | Humphries William D. Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2022-06-02 | Humphries William D. Director | Grant or award · Restricted Stock Units | +4,507 | 4,507 | ||
| 2022-06-02 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | ||
| 2022-06-02 | GOWEN MAXINE Director | Grant or award · Restricted Stock Units | +4,507 | 4,507 | ||
| 2022-05-16 | Powell Andrew Kenneth William Director | Gift | −709 | 10,500 | ||
| 2022-04-25 | Walker Neal President and CEO | Sale | −20,000 | $15.18 | $304K | 1,245,763 |
| 2022-04-22 | Walker Neal President and CEO | Sale | −25,000 | $15.04 | $376K | 1,265,763 |
| 2022-04-21 | Walker Neal President and CEO | Sale | −25,000 | $15.24 | $381K | 1,290,763 |
| 2022-04-18 | Monahan Joseph Chief Scientific Officer | Sale | −30,000 | $16.28 | $488K | 106,386 |
| 2022-03-11 | Walker Neal President and CEO | Sale | −56,303 | $15.91 | $896K | 1,315,763 |
| 2022-03-10 | Ruffo Frank Chief Financial Officer | Sale | −12,823 | $15.55 | $199K | 201,883 |
| 2022-03-10 | Monahan Joseph Chief Scientific Officer | Sale | −27,165 | $15.71 | $427K | 136,386 |
| 2022-03-02 | Monahan Joseph Chief Scientific Officer | Option exercise | +12,500 | 163,551 | ||
| 2022-03-02 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted stock units | −12,500 | 25,000 | ||
| 2022-03-02 | Ruffo Frank Chief Financial Officer | Option exercise | +8,297 | 214,706 |
Page 25 of 34 · 680 trades